The authors report a possible association between posaconazole, a new systemic antifungal, and eyelid granulomata. A 12-year-old boy presented with a 2-week history of bilateral eyelid granulomata. They were noted to reduce in size and symptoms when posaconazole was discontinued. Symptoms increased when the drug was restarted.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/MJT.0b013e3181a09d10 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!